A Cambridge company’s technology which can cut the diagnosis times for rare genetic diseases is being made available on the NHS.
Related News Articles
£2bn cost of mental ill health in the North
New report finds that mental health in the North was disproportionately affected during the pandemic.
A successful delegation to Biomed Israel 2022
Our Cluster Development Manager, Dr Ben Martyn, reflects on the interactions and opportunities across the week-long delegation.
Guest Blog: Exploring the future of the mental healthcare system
A guest Biomed Israel blog from Heather Rice, Assistant Director of Research, RDaSH NHS Foundation Trust.